Pharmacogenetics and statin-related myopathy: what do we know?

Pharmacogenomics. 2020 Aug;21(12):821-825. doi: 10.2217/pgs-2020-0041. Epub 2020 Jul 29.
No abstract available

Keywords: SLCO1B1; adverse drug reaction; drug-induced muscle injury; myopathy; rhabdomyolysis; statin.

Publication types

  • Editorial

MeSH terms

  • Atherosclerosis / drug therapy
  • Atherosclerosis / genetics
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Liver-Specific Organic Anion Transporter 1 / genetics*
  • Muscular Diseases / chemically induced*
  • Muscular Diseases / genetics*
  • Muscular Diseases / prevention & control
  • Pharmacogenetics / methods
  • Pharmacogenetics / trends*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Liver-Specific Organic Anion Transporter 1
  • SLCO1B1 protein, human